Novartis suspends two cancer therapies over quality concerns

Zurich: Novartis said on Thursday it had temporarily suspended the production of its Lutathera and Pluvicto cancer therapies at facilities in Italy and New Jersey after potential quality issues were...

Related Keywords

Italy ,Zurich ,Züsz ,Switzerland ,New Jersey ,United States ,Spain ,Swiss , ,Novartis ,Novartis News ,Lutathera ,Pluvicto ,Cancer Therapies ,Cancer ,Radioligand Therapies ,Nuclear Medicine ,